ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
7 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
8 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Mistlefoot
|
120 |
44K |
10 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
44K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical and Philips sign Memorandum of Understanding
|
|
Mistlefoot
|
70 |
21K |
5 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
70
|
21K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Margin per procedure
|
|
Mistlefoot
|
8 |
2.5K |
3 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
8
|
2.5K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Margin per procedure
|
|
Mistlefoot
|
8 |
2.5K |
7 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
8
|
2.5K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical and Philips sign Memorandum of Understanding
|
|
Mistlefoot
|
70 |
21K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
70
|
21K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical and Philips sign Memorandum of Understanding
|
|
Mistlefoot
|
70 |
21K |
14 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
70
|
21K
|
14
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. CMS Approves Reimbursement for 4DMedical
|
|
Mistlefoot
|
150 |
67K |
14 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
150
|
67K
|
14
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical Investor Webinar Details
|
|
Mistlefoot
|
28 |
8.6K |
5 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
28
|
8.6K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Mistlefoot
|
111 |
35K |
4 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
111
|
35K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
Mistlefoot
|
52 |
20K |
10 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
20K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Pause in Trading
|
|
Mistlefoot
|
31 |
8.1K |
4 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
31
|
8.1K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Mistlefoot
|
733 |
325K |
6 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
733
|
325K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Mistlefoot
|
733 |
325K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
733
|
325K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
Mistlefoot
|
78 |
26K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
78
|
26K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
Mistlefoot
|
78 |
26K |
8 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
78
|
26K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2023
|
|
Mistlefoot
|
21 |
7.1K |
2 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
21
|
7.1K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2023
|
|
Mistlefoot
|
21 |
7.1K |
13 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
21
|
7.1K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX provides further info on US hospital SaaS contract
|
|
Mistlefoot
|
35 |
17K |
11 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
35
|
17K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
Mistlefoot
|
158 |
69K |
15 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
158
|
69K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2023
|
|
Mistlefoot
|
64 |
23K |
1 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
64
|
23K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2023
|
|
Mistlefoot
|
64 |
23K |
6 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
64
|
23K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
The AGM thoughts...
|
|
Mistlefoot
|
13 |
5.4K |
4 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
5.4K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
4 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
2.4K
|
1.0M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2022
|
|
Mistlefoot
|
4 |
3.8K |
10 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
4
|
3.8K
|
10
|
|
ASX - By Stock
|
FAR |
Re:
Ann: Executive Change
|
|
Mistlefoot
|
73 |
40K |
13 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
73
|
40K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical unveils world's first dedicated lung scanner
|
|
Mistlefoot
|
43 |
18K |
8 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
43
|
18K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
3 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
2.4K
|
1.0M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical partners with RCI for clinical pilot program
|
|
Mistlefoot
|
57 |
22K |
1 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
57
|
22K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Voluntary Suspension
|
|
Mistlefoot
|
95 |
37K |
1 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
95
|
37K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Voluntary Suspension
|
|
Mistlefoot
|
95 |
37K |
1 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
95
|
37K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Mistlefoot
|
38 |
21K |
9 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
38
|
21K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives TGA approval for XV LVAS
|
|
Mistlefoot
|
22 |
21K |
2 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
22
|
21K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
4 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
2.4K
|
1.0M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
How much can it go tomorrow?
|
|
Mistlefoot
|
109 |
71K |
1 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
109
|
71K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
How much can it go tomorrow?
|
|
Mistlefoot
|
109 |
71K |
8 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
109
|
71K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mistlefoot
|
2.4K |
1.0M |
2 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.4K
|
1.0M
|
2
|
|